C12Y 305/02006
Beta-lactamase
Official title: Beta-lactamase (3.5.2.6)
C12Y305/02006 (Beta-lactamase) appears on 130 US grants and 152 published applications in this corpus.
Search patents in C12Y- Granted patents
- 130
- Published applications
- 152
- Assignees
- 76
- Inventors
- 257
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 8 | 0 |
| 2002 | 8 | 1 |
| 2003 | 4 | 3 |
| 2004 | 1 | 2 |
| 2005 | 0 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 7 |
| 2009 | 0 | 3 |
| 2010 | 1 | 4 |
| 2011 | 4 | 4 |
| 2012 | 4 | 2 |
| 2013 | 3 | 3 |
| 2014 | 2 | 2 |
| 2015 | 2 | 3 |
| 2016 | 7 | 11 |
| 2017 | 5 | 10 |
| 2018 | 5 | 11 |
| 2019 | 5 | 9 |
| 2020 | 9 | 15 |
| 2021 | 6 | 12 |
| 2022 | 10 | 13 |
| 2023 | 11 | 14 |
| 2024 | 8 | 11 |
| 2025 | 5 | 3 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heterologous proteins with axonemal proteins7 Jul 2026US 12,673,977 B2The Regents of the University of California
- Mammalian expression vectors30 Jun 2026US 12,668,809 B2Biocon Biologics Limited
- Compositions and methods for enzyme immobilization21 Apr 2026US 12,606,813 B2AgroSpheres, Inc.
- Compositions and methods for adoptive cell therapy16 Dec 2025US 12,496,310 B2Memorial Sloan Kettering Cancer Center
- Optical transmission sample holder and analysis, particularly for hemoglobin22 Jul 2025US 12,366,520 B2Essenlix Corporation
- Biosensor comprising a modified beta-lactamase and uses thereof10 Sep 2026US 2026/0265724 A1The Hong Kong Polytechnic University
- Peptide inhibitors of beta-lactamase16 Jul 2026US 2026/0200978 A1The Curators of the University of Missouri
- Pharmaceutical combination for the treatment of multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma9 Jul 2026US 2026/0191834 A1
- Compositions and methods for enzyme immobilization9 Jul 2026US 2026/0193636 A1AgroSpheres, Inc.
- Optical transmission sample holder and analysis, particularly for hemoglobin25 Sep 2025US 2025/0297942 A1Essenlix Corporation
Most cited
By later US patents
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination531US 6,117,679 AMaxygen, Inc. · 2000
- Methods of shuffling polynucleotides373US 6,132,970 AMaxygen, Inc. · 2000